Old Web
English
Sign In
Acemap
>
authorDetail
>
Sophie Kitzmüller
Sophie Kitzmüller
Clinical trial
Medicine
Placebo
Dermatology
Orphan drug
4
Papers
41
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Small molecule drug development for rare genodermatoses - evaluation of the current status in epidermolysis bullosa.
2020
Orphanet Journal of Rare Diseases
Verena Wally
Manuela Reisenberger
Sophie Kitzmüller
Martin Laimer
Show All
Source
Cite
Save
Citations (3)
Iconography : Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial
2018
Journal of The American Academy of Dermatology
Verena Wally
Alain Hovnanian
Juliette Ly
Hana Buckova
Victoria Brunner
Thomas Lettner
Michael Ablinger
Thomas K. Felder
Peter Hofbauer
Martin Wolkersdorfer
Florian B Lagler
Wolfgang Hitzl
Martin Laimer
Sophie Kitzmüller
Anja Diem
Johann Bauer
Show All
Source
Cite
Save
Citations (0)
Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial
2018
Journal of The American Academy of Dermatology
Verena Wally
Alain Hovnanian
Juliette Ly
Hana Buckova
Victoria Brunner
Thomas Lettner
Michael Ablinger
Thomas K. Felder
Peter Hofbauer
Martin Wolkersdorfer
Florian B Lagler
Wolfgang Hitzl
Martin Laimer
Sophie Kitzmüller
Anja Diem
Johann W. Bauer
Show All
Source
Cite
Save
Citations (25)
Transgenic mouse technology in skin biology: generation of complete or tissue-specific knockout mice.
2014
Journal of Investigative Dermatology
Lukas Scharfenberger
Tina Hennerici
Gabor Kiraly
Sophie Kitzmüller
Marigje Vernooij
Julia Zielinski
Show All
Source
Cite
Save
Citations (13)
1